Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gabriel S. Breuer is active.

Publication


Featured researches published by Gabriel S. Breuer.


The Journal of Rheumatology | 2009

Rate of Discordant Findings in Bilateral Temporal Artery Biopsy to Diagnose Giant Cell Arteritis

Gabriel S. Breuer; Gideon Nesher; Ronit Nesher

Objective. To determine to what extent performing simultaneous bilateral temporal artery biopsies might increase the diagnostic sensitivity in giant cell arteritis (GCA). Methods. In total 173 consecutive pathology reports of temporal artery biopsies were reviewed for histological findings by a single pathologist. The rate of discordance of biopsy results was calculated in patients with GCA. Results. Biopsies were performed bilaterally and simultaneously in 132 cases; 51 had positive results. In 38 the biopsy was positive on both sides (concordant results), while in 13 patients only one side was positive (discordant results), reaching a discordance rate of 13/51 = 0.255. Therefore 12.7% of the patients (one-half of the discordance rate) could have been misdiagnosed as biopsy-negative had a biopsy been done only unilaterally in those 51 cases. Conclusion. These data suggest that performing bilateral temporal artery biopsies increases the diagnostic sensitivity of the procedure by up to 12.7%, compared to unilateral biopsies.


Journal of Clinical Gastroenterology | 2001

A pregnant woman with hepatitis A and Guillain-Barré.

Gabriel S. Breuer; Gilles Morali; Yoram Finkelstein; Jonathan Halevy

Guillain-Barré syndrome (GBS) is often preceded by an infectious disease. A case of GBS after hepatitis A in a pregnant woman is described. The patient was treated with intravenous immunoglobulin and had full recovery with no neurologic sequelae. She gave birth in term to a healthy baby. This is the first reported case in the English literature of a triple condition of hepatitis A, GBS, and pregnancy.


Journal of Critical Care | 2012

Predictors of mortality of mechanically ventilated patients in internal medicine wards.

Moshe Hersch; Gabriel Izbicki; David Dahan; Gabriel S. Breuer; Gideon Nesher; Sharon Einav

PURPOSE Budget restrictions have led to shortage of intensive care unit (ICU) beds in several countries. Consequently, ventilated patients are often kept on the wards. This study examined survival likelihood among patients ventilated on the wards and the predictive value of commonly used severity-of-illness scores. METHODS This study is a prospective observation and characterization of consecutive, mechanically ventilated patients in 3 internal medicine wards of a single hospital who were denied ICU admission. Outcome measures are as follows: 28-day mortality, survival to hospital discharge, and 3 months postdischarge. RESULTS Eighty-six patients were examined. The patients were 78.9 ± 8.9 years old; 53% were independent preadmission. Respiratory insufficiency due to infection was the main reason for mechanical ventilation (58%). Charlson and acute physiology scores (APS) averaged 4 ± 2.2 and 91.8 ± 26.7, respectively. Twenty-eight-day mortality was 71%, whereas in-hospital mortality was 74% and 3 months postdischarge mortality was 79%. Survivors were significantly younger than nonsurvivors (74.4 ± 8.5 years vs 80.4 ± 8.6 years, P < .01), were more likely to be ventilated for cardiac causes (41% vs 11%, P = .04), and had significantly higher initial mean blood pressure (79.4 mm Hg vs 58.2 mm Hg, P = .02) and blood albumin levels (29.8 g/L vs 25.7 g/L, P = .05). Death rate was 10 times more likely, with an APS greater than 90 on the day of intubation as compared with an APS less than 90. CONCLUSION Mortality in patients ventilated on the ward was high, especially in the subgroup of patients with an APS score greater than 90. The early calculation of APS may assist in focusing therapeutic efforts on patients with better survival chances.


Rambam Maimonides Medical Journal | 2016

Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update

Gideon Nesher; Gabriel S. Breuer

Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are both more common among people of North European decent than among Mediterranean people. Women are 2–3 times more commonly affected. Giant cell arteritis and PMR are extremely rare before age 50 years. Polymyalgia rheumatica may be “isolated” or associated with GCA. There is increased expression of inflammatory cytokines in temporal arteries of PMR patients, without overt histological evidence of arteritis. One-third of “isolated” PMR patients have vascular uptake in positron emission tomography (PET) scans, suggesting clinically unrecognized, “hidden” GCA. Typical manifestations of GCA are headache, tenderness over temporal arteries, jaw claudication, PMR, acute vision loss, and low-grade fever. Bilateral aching of the shoulders with morning stiffness is typical for PMR. In both conditions sedimentation rate and C-reactive protein are elevated, and anemia and thrombocytosis may occur. Color duplex ultrasonography of the temporal arteries may aid in GCA diagnosis. Temporal artery biopsy showing vasculitis, often with giant cells, confirms GCA diagnosis. In cases with negative biopsy one must rely on the clinical presentation and laboratory abnormalities. The diagnosis of PMR is made primarily on clinical grounds. Other conditions that may mimic GCA or PMR must be excluded. Glucocorticoids are the treatment of choice for both conditions. Prompt treatment is crucial in GCA, to prevent irreversible complications of acute vision loss and stroke. Addition of low-dose aspirin may further prevent these complications. The average duration of treatment is 2–3 years, but some patients require a prolonged course of treatment, and some may develop disease-related or treatment-related complications. No steroid-sparing agent has been proven to be widely effective thus far, but some promising therapeutic agents are currently being studied.


International Journal of Rheumatic Diseases | 2016

Dual‐energy computed tomography as a diagnostic tool for gout during intercritical periods

Gabriel S. Breuer; Naama Bogot; Gideon Nesher

The aim of this study is to evaluate the diagnostic yield of dual‐energy computed tomography (DECT) in detection of uric acid accumulation in joints or periarticular structures in patients suspected of having gout, in their intercritical period.


The Journal of Rheumatology | 2016

The Incidence of Primary Systemic Vasculitis in Jerusalem: A 20-year Hospital-based Retrospective Study

Gideon Nesher; Eli Ben-Chetrit; Bracha Mazal; Gabriel S. Breuer

Objective. The incidence of primary systemic vasculitides varies among different geographic regions and ethnic origins. The aim of this study was to examine the incidence rates of vasculitides in the Jerusalem Jewish population, and to examine possible trends in incidence rates over a 20-year period. Methods. The clinical databases of inpatients at the 2 medical centers in Jerusalem were searched for patients with vasculitis diagnosed between 1990–2009. Individual records were then reviewed by one of the authors. The significance of trends in incidence rates throughout the study period was evaluated by Pearson correlation coefficient. Results. The average annual incidence rate of polyarteritis nodosa was 3.6/million adults (95% CI 1.6–4.7). Incidence rates did not change significantly during this period (r = 0.39, p = 0.088). The incidence of granulomatosis with polyangiitis (GPA) was 4.1 (2.2–5.9) for the whole period, during which it increased significantly (r = 0.53, p < 0.05). The incidence of microscopic polyangiitis (MPA) was lower: 2.3 (1.2–3.5)/million. It also increased significantly (r = 0.55, p < 0.05). The incidence of eosinophilic granulomatosis with polyangiitis was 1.2 (0.4–1.9), which remained stable throughout the study period. The incidence of Takayasu arteritis was 2.1/million (95% CI 1.2–2.9), and it also remained stable. Giant cell arteritis (GCA) incidence was 8.1 (5.7–10.6)/100,000 population aged 50 years or older. In sharp contrast with other vasculitides, its incidence decreased significantly throughout the study period (r = −0.61, p < 0.01). Conclusion. The incidence rates of vasculitides in the Jewish population of Jerusalem are in the lower range of global incidence rates. While GPA and MPA incidence are increasing, GCA incidence is decreasing.


The Journal of Rheumatology | 2014

Erysipelas-like erythema in a patient with familial Mediterranean fever.

Gabriel S. Breuer; Joel D. Taurog

A rare skin manifestation of familial Mediterranean fever (FMF) usually appears in the lower extremities and can be brought on by physical exertion. A 19-year-old white male was presented to the emergency room with a chief complaint of a painful red discoloration of the ankles of 3 days’ duration with accompanying fever. The patient had been diagnosed with FMF at the age of 6 years, based on recurrent episodes of fever, abdominal pain, and foot pain beginning at the …


Seminars in Arthritis and Rheumatism | 2006

Lupus-Associated Pancreatitis

Gideon Nesher; Gabriel S. Breuer; Katherine Temprano; Terry L. Moore; David Dahan; Asher Baer; Joseph Alberton; Gabriel Izbicki; Moshe Hersch


International Journal of Antimicrobial Agents | 2006

Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea

David Raveh; Bella Rabinowitz; Gabriel S. Breuer; Bernard Rudensky; Amos M. Yinnon


Israel Medical Association Journal | 2006

Use of complementary and alternative medicine among patients attending rheumatology clinics in Israel.

Gabriel S. Breuer; Hedi Orbach; Ori Elkayam; Yaakov Berkun; Dafna Paran; Michal Mates; Gideon Nesher

Collaboration


Dive into the Gabriel S. Breuer's collaboration.

Top Co-Authors

Avatar

Gideon Nesher

Shaare Zedek Medical Center

View shared research outputs
Top Co-Authors

Avatar

Gideon Nesher

Shaare Zedek Medical Center

View shared research outputs
Top Co-Authors

Avatar

Moshe Hersch

Shaare Zedek Medical Center

View shared research outputs
Top Co-Authors

Avatar

Bernard Rudensky

Shaare Zedek Medical Center

View shared research outputs
Top Co-Authors

Avatar

David Dahan

Shaare Zedek Medical Center

View shared research outputs
Top Co-Authors

Avatar

Gabriel Izbicki

Shaare Zedek Medical Center

View shared research outputs
Top Co-Authors

Avatar

Michal Mates

Shaare Zedek Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sharon Einav

Shaare Zedek Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge